Ignite Creation Date:
2025-12-26 @ 12:15 PM
Ignite Modification Date:
2026-01-01 @ 2:14 AM
Study NCT ID:
NCT04145700
Status:
TERMINATED
Last Update Posted:
2023-09-13
First Post:
2019-10-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-03-04
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-02-23
Completion Date Type:
ACTUAL
First Submit Date:
2019-10-29
First Submit QC Date:
None
Study First Post Date:
2019-10-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-08-23
Results First Submit QC Date:
None
Results First Post Date:
2023-09-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-23
Last Update Post Date:
2023-09-13
Last Update Post Date Type:
ACTUAL